Interpretative reading: recognizing the unusual and inferring resistance mechanisms from resistance phenotypes

被引:180
作者
Livermore, DM
Winstanley, TG
Shannon, KP
机构
[1] Cent Publ Hlth Lab, Antibiot Resistance Monitoring & Reference Lab, London NW9 5HT, England
[2] Royal Hallamshire Hosp, Dept Microbiol, Sheffield S10 2JF, S Yorkshire, England
[3] Univ London Kings Coll, St Thomas Hosp, Guys Kings & St Thomas Sch Med, Dept Infect, London SE1 7EH, England
关键词
D O I
10.1093/jac/48.suppl_1.87
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
If isolates are speciated and if a sufficient range of antibiotics is tested, underlying resistance mechanisms can often be inferred from the antibiogram data. This allows: (i) anomalous combinations of phenotype and organism to be reconsidered; (ii) prediction of further antibiotics that deserve testing; and (iii) the suppression of susceptibilities that are anomalous in the light of the inferred mechanism. This 'interpretative reading' is widely undertaken in France but is largely precluded in the UK by limited speciation and the testing of narrow ranges of antibiotics. Nevertheless, UK laboratories should be aware of: (i) grossly anomalous combinations of species and phenotype, demanding reference laboratory confirmation; (ii) useful indicator drugs, where resistance implies a mechanism conferring other resistances that may be less obvious in direct tests; and (iii) antibiotics that are prone to select resistant mutants of particular species during therapy. Details of these combinations of organism and resistance are presented. Relationships between antibiogram and mechanism are also presented to allow full interpretative reading for those testing wide panels of drugs versus speciated isolates.
引用
收藏
页码:87 / 102
页数:16
相关论文
共 43 条
[1]   BSAC standardized disc susceptibility testing method [J].
Andrews, JM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 :43-57
[2]  
AYLIFFE G, 1978, LAB METHODS ANTIMICR, P112
[3]   A review of the comparative in-vitro activities of 12 antimicrobial agents, with a focus on five new 'respiratory quinolones' [J].
Blondeau, JM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 :1-11
[4]   CTX-M-5, a novel cefotaxime-hydrolyzing β-lactamase from an outbreak of Salmonella typhimurium in Latvia [J].
Bradford, PA ;
Yang, YJ ;
Sahm, D ;
Grope, I ;
Gardovska, D ;
Storch, G .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (08) :1980-1984
[5]   Detection of methicillin/oxacillin resistance in staphylococci [J].
Brown, DFJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 :65-70
[6]   A FUNCTIONAL CLASSIFICATION SCHEME FOR BETA-LACTAMASES AND ITS CORRELATION WITH MOLECULAR-STRUCTURE [J].
BUSH, K ;
JACOBY, GA ;
MEDEIROS, AA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (06) :1211-1233
[7]   CLONING AND CHARACTERIZATION OF AN AAC(6') GENE FROM SERRATIA-MARCESCENS [J].
CHAMPION, HM ;
BENNETT, PM ;
LEWIS, DA ;
REEVES, DS .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1988, 22 (05) :587-596
[8]  
Courvalin P., 1992, ASM NEWS, V58, P368, DOI DOI 10.1111/J.1469-0691.1996.TB00872.X
[9]  
Duncan I B, 1967, Antimicrob Agents Chemother (Bethesda), V7, P723
[10]   Complexity and diversity of Klebsiella pneumoniae strains with extended-spectrum β-lactamases isolated in 1994 and 1996 at a teaching hospital in Durban, South Africa [J].
Essack, SY ;
Hall, LMC ;
Pillay, DG ;
McFadyen, ML ;
Livermore, DM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (01) :88-95